Market Performance - Southeast Asia ETFs rose by 4.81%, with Vietnam leading the gains[2] - The Global X FTSE Southeast Asia ETF outperformed ETFs tracking India, the UK, and China, but lagged behind Japan, Latin America, and the US[2] - The Southeast Asia Technology ETF increased by 4.47%, underperforming the broader Southeast Asia ETF by 0.34 percentage points[2] Country-Specific Insights - iShares MSCI Indonesia ETF gained 5.05%, outperforming by 0.24 percentage points, with active trading following a modest pullback[3] - iShares MSCI Singapore ETF rose 4.56%, underperforming by 0.25 percentage points, supported by the 2025 GST voucher scheme for low-income households[3] - iShares MSCI Thailand ETF advanced 2.69%, underperforming by 2.12 percentage points, aided by a central bank interest rate cut[3] - iShares MSCI Malaysia ETF climbed 4.17%, underperforming by 0.64 percentage points, as the US-Malaysia tariff agreement took effect[3] - Global X MSCI Vietnam ETF surged 11.83%, outperforming by 7.02 percentage points, driven by financial hub development and supportive central bank policies[3] Trading Volume and Liquidity - The Global X FTSE Southeast Asia ETF had a trading volume of 188,000 shares, increasing by 19.5%[16] - iShares MSCI Indonesia ETF trading volume reached 7,054,000 shares, up by 9.5%[16] - iShares MSCI Singapore ETF trading volume decreased by 15.8% to 5,379,000 shares[16] Risk Factors - The report highlights macroeconomic downturn risks and geopolitical tensions as potential threats to market stability[4][36]

Investment Rating - The report maintains an "Outperform" rating for the computer industry, expecting a relative return exceeding the benchmark index by over 10% in the next 12-18 months [5][27]. Core Insights - The Ministry of Industry and Information Technology has issued guidelines to promote the development of the brain-computer interface industry, which is expected to enhance high-quality growth and innovation [10]. - The release of GPT-5 on August 8, 2025, has significantly reduced costs and is anticipated to benefit AI applications in the long term, accelerating the implementation of AI technologies [9][11]. - The World Robot Conference, held from August 8-12, 2025, showcases advancements in robotics and AI, featuring over 200 companies and focusing on embodied intelligence applications across various sectors [12]. Summary by Sections Industry Development - The guidelines aim for breakthroughs in key technologies by 2027, establishing a secure industry system by 2030 with 2-3 globally influential enterprises and a competitive ecosystem [10]. GPT-5 Release - GPT-5 has shown improvements in reliability, efficiency, and cost, with a 45% reduction in hallucination rates compared to GPT-4 and an 80% reduction compared to OpenAI o3, enhancing its practical applications in software development and content production [11]. - The context processing capability of GPT-5 supports 400k tokens, doubling the accuracy of long-text generation compared to previous versions [11]. Recommended Stocks - The report recommends focusing on companies such as Kingdee International, Kingsoft Office, Hand Enterprise, and others, which are expected to benefit from the positive outlook in the computer sector [5][9].

Investment Rating - The report maintains an "Outperform" rating for the company, expecting a relative increase of over 10% compared to the benchmark index in the next 12-18 months [4][17]. Core Insights - The company achieved high-quality and steady growth in the first half of 2025, with significant profit performance and continuous innovation in AI retail products, positioning it to benefit from technological changes in the industry [1][4]. - Revenue for the first half of 2025 reached 1.078 billion RMB, a year-on-year increase of 14.8%, while gross profit was 414 million RMB, up 15.2% [4]. - The company has a strong customer retention rate, with a net revenue retention rate of 107%, and has successfully expanded its customer base by signing contracts with notable clients [4][5]. Financial Summary - The company is projected to achieve total revenue of 2.222 billion RMB in 2025, with a compound annual growth rate (CAGR) of 19.5% from 2023 to 2025 [3][4]. - The forecasted net profit attributable to the parent company is expected to turn positive in 2025, reaching 151 million RMB, with further increases to 270 million RMB in 2026 and 411 million RMB in 2027 [3][4]. - The report provides a dynamic price-to-sales (PS) ratio of 5.5 for 2025, with a target price of 14.18 HKD, based on a conversion rate of 1 HKD = 0.92 RMB [4][5]. Customer and Product Development - The company has implemented a dual-driven strategy focusing on both existing and new customers, leading to a significant increase in revenue from independent clients, which grew by 44.21% year-on-year [4]. - New AI-driven retail solutions have been launched, including systems for supply chain management and store operations, enhancing operational efficiency and product offerings [4][5].

Investment Rating - Maintain "Outperform" rating with a target price of 19.41 HKD for 2025, reflecting a dynamic PS of 9x [4][10]. Core Insights - The company is experiencing robust revenue growth, with a projected revenue of 6.99 billion RMB for 2025, and a net profit attributable to shareholders expected to reach 0.09 billion RMB [4][10]. - The cloud transformation is entering a harvest phase, evidenced by a 11.2% year-on-year revenue increase to 3.19 billion RMB in the first half of 2025, and a significant narrowing of net profit loss by 55.1% [11][12]. - AI integration into SaaS products is progressing well, with AI contract values exceeding 0.15 billion RMB, indicating strong demand for AI applications in enterprise management [13]. Financial Summary - Total revenue projections for 2023 to 2027 are as follows: 5.68 billion RMB in 2023, 6.26 billion RMB in 2024, 6.99 billion RMB in 2025, 7.93 billion RMB in 2026, and 9.15 billion RMB in 2027, reflecting a compound annual growth rate (CAGR) of approximately 15.4% from 2023 to 2027 [3][4]. - Gross profit is expected to grow from 3.64 billion RMB in 2023 to 6.41 billion RMB in 2027, with a gross margin improvement from 65.07% in 2024 to 70% in 2027 [8]. - The company anticipates a return to profitability with net profit projections of 0.09 billion RMB in 2025, 0.30 billion RMB in 2026, and 0.56 billion RMB in 2027, marking a significant turnaround from a net loss of 0.21 billion RMB in 2023 [3][4]. Cloud Business Performance - Cloud service revenue reached 2.67 billion RMB in the first half of 2025, up 11.9% year-on-year, with cloud subscription revenue contributing significantly to total revenue [11][12]. - The annual recurring revenue (ARR) from cloud subscriptions is projected to be 3.73 billion RMB, reflecting an 18.5% year-on-year growth [11][12]. - The company has achieved a 24.7% increase in cloud subscription contractual liabilities, indicating strong future revenue visibility [11][12]. AI Business Development - The company has successfully integrated AI into its SaaS offerings, with AI contract values surpassing 0.15 billion RMB in the first half of 2025 [13]. - New AI products launched include Cangqiong AI Agent 2.0 and various intelligent assistants, which have attracted key clients such as Hisense and Tongwei [13].

Investment Rating - The report maintains a positive outlook on ExxonMobil, indicating a favorable investment rating based on strong performance in upstream operations [1][2]. Core Insights - ExxonMobil reported adjusted net income of $7.082 billion for Q2 2025, slightly below consensus expectations of $7.082 billion, driven by robust performance in upstream operations [1][2]. - The company reaffirmed its capital expenditure guidance for FY 2025 in the range of $27-29 billion and confirmed a quarterly dividend of $0.99 per share, consistent with Q1 2025 [1]. - ExxonMobil also confirmed a $20 billion stock buyback plan to be maintained through 2026 [1]. Summary by Relevant Sections Upstream Business Performance - The upstream segment achieved adjusted net income of $5.402 billion, exceeding consensus expectations of $4.764 billion, supported by increased production from the Permian Basin and Guyana projects, structural cost savings, favorable exchange rates, and tax impacts, partially offset by price declines [2][4]. - Oil and gas production reached 4.63 million barrels of oil equivalent per day, reflecting a 13% year-over-year increase in H1 2025 [2]. Energy Products - The energy products segment reported adjusted net income of $1.365 billion, surpassing consensus expectations of $1.265 billion, as cost savings and planned maintenance mitigated the impact of declining refining margins [2][4]. Chemical Products - The chemical segment's adjusted net income was $293 million, falling short of consensus expectations of $427 million, primarily due to narrowing margins and increased spending related to projects in China, although partially offset by structural cost savings [2][4]. Specialty Products - The specialty products segment reported adjusted net income of $780 million, exceeding expectations of $728 million, as margin improvements and cost savings offset increased expenses [2][4].

Investment Rating - The report indicates a positive outlook for Saudi Basic Industries Corporation (SABIC) with a focus on stable performance and ongoing project progress [1][2]. Core Insights - SABIC's Q2 2025 performance was favorable, with adjusted net income of 480 million SAR, slightly below consensus expectations, but strong performance in petrochemicals and agricultural nutrients [1][2]. - The company has revised its FY25 capital expenditure guidance down from 3.5-4.0 billion USD to 3.0-3.5 billion USD, while emphasizing that key projects in China and Saudi Arabia are progressing on budget and schedule [1][2]. - Revenue reached 35.6 billion SAR, exceeding market expectations, driven by strong performance in petrochemicals and agricultural nutrients [2][4]. Summary by Sections Financial Performance - Net revenue for Q2 2025 was 35,570 million SAR, a 3% increase quarter-over-quarter, and stable year-over-year [4]. - Adjusted EBITDA was 5,220 million SAR, reflecting a 109% increase from the previous quarter, with a margin of 15% [4]. - Adjusted net income was 480 million SAR, showing a significant recovery from a loss of 1,210 million SAR in Q1 2025 [4]. Business Segments - **Petrochemicals & Specialties**: Revenue was 32,400 million SAR, a 3% increase quarter-over-quarter, with a strong EBITDA of 3,980 million SAR, marking a 180% increase [4]. - **Agri-Nutrients**: Revenue reached 3,160 million SAR, a 2% increase quarter-over-quarter and a 32% increase year-over-year, with EBITDA of 1,240 million SAR, a 15% increase [4]. Project Updates - Key growth projects, including the Petrokemya MTBE plant and the SABIC Fujian complex, are on track for completion, with the latter expected to commence production in the second half of 2026 [2][4].

Investment Rating - The report maintains a positive outlook on JGC Holdings, indicating that the first quarter performance is likely to be viewed favorably by the market despite net income being below consensus due to foreign exchange losses [1][2]. Core Insights - JGC Holdings reported a net income of 5.6 billion yen for the first quarter of 2025, which was below the consensus estimate of approximately 7 billion yen, primarily impacted by foreign exchange losses of 3.7 billion yen. However, revenue exceeded market expectations with a gross margin of 8%, surpassing the consensus estimate of about 7% [2][3]. - The company reaffirmed its guidance for the fiscal year 2025, projecting revenue of 690 billion yen, gross profit of 52 billion yen (gross margin of 7.5%), operating income of 21 billion yen, and net income of 15 billion yen, while maintaining a dividend target of 40 yen per share [2][3]. - New order intake has significantly lagged behind guidance, with a target of 650 billion yen for the fiscal year 2025, but only 47 billion yen in orders secured in the first quarter, achieving just 7% of the target. However, the company secured significant contracts in July, which are expected to support the achievement of its order targets for the fiscal year [3]. Summary by Sections Financial Performance - For the first quarter of 2025, JGC Holdings reported net revenue of 19 billion yen, a decrease of 25% quarter-on-quarter but a 5% increase year-on-year. The operating cost was 17.4 billion yen, down 27% quarter-on-quarter and down 7% year-on-year. The gross profit was 15.4 billion yen, reflecting a gross margin of 8% [5]. Guidance and Orders - The company reiterated its fiscal year 2025 guidance, forecasting revenue of 690 billion yen, gross profit of 52 billion yen, operating income of 21 billion yen, and net income of 15 billion yen. The dividend target remains at 40 yen per share [2][3]. - The new order guidance for fiscal year 2025 is set at 650 billion yen, with 500 billion yen expected from overseas markets and 150 billion yen from domestic markets. The first quarter saw only 47 billion yen in new orders, but recent contract wins are expected to bolster future order intake [3].

Investment Rating - The report does not explicitly state an investment rating for Chevron (CVX US) but indicates a positive outlook for the company's performance in the market for the second quarter of 2025 [1]. Core Insights - Chevron reported adjusted net income of $3.053 billion for Q2 2025, slightly below the consensus estimate of $3.116 billion, primarily due to weak performance in the upstream segment [2]. - The company maintained its quarterly dividend at $1.71 per share and reiterated its guidance for $15 billion in organic capital expenditures for FY 2025 [1][2]. - Chevron's stock buyback amounted to $2.6 billion in the second quarter, down from $3.9 billion in the first quarter of 2025 [1]. Summary by Sections Financial Performance - Adjusted net income for Q2 2025 was $3.053 billion, a decrease of 20% quarter-over-quarter and 35% year-over-year [5]. - Revenue for Q2 2025 was $44.822 billion, reflecting a 6% decline from the previous quarter and a 12% decline year-over-year [5]. - Adjusted free cash flow for Q2 2025 was $4.9 billion, compared to $4.2 billion in Q1 2025, against a guidance of $10 billion [2]. Upstream Segment - The upstream segment reported adjusted net income of $2.727 billion, with production levels at 1.701 million barrels of oil equivalent per day, showing a slight decrease of approximately 1% quarter-over-quarter and year-over-year [2][3]. Downstream Segment - The downstream segment achieved a profit of $737 million, benefiting from improved refining margins that offset weaker performance in the chemicals business [3].

[Table_Title] 研究报告 Research Report 18 Aug 2025 Presight AI (PRESIGHT UH) 盈利强劲增长；上调中期指引 Scott Darling Catherine Li scott.darling@htisec.com catherine.dy.li@htisec.com [Table_yemei1] 热点速评 Flash Analysis [Table_summary] 要闻回顾以及最新动态 我们预计市场将把 Presight AI 的 2025 年第二季度业绩视为偏利好。公司录得息税折摊前利润基本符合一致预期。 本季公司订单储备保持稳健，并上调了中期增长指引。 点评 营收表现稳健：2025 年第二季度营收约 5.24 亿阿联酋迪拉姆（其中 AIQ 贡献 1.58 亿阿联酋迪拉姆），季环比下降 7%，略低于约 5.4 亿阿联酋迪拉姆的一致预期，得益于新订单增长以及稳健的 AIQ 贡献。息税折摊前利润达 1.05 亿 阿联酋迪拉姆，符合一致预期。息税折摊前利润率为 20%（2025 年第一季度 25%，2024 年第四季度 35.1%，2024 财年 ...

Investment Rating - The report maintains an "Outperform" rating for JD Health International with a target price of HKD 68.14, reflecting a significant upward revision of 58.8% from previous estimates [2][21]. Core Insights - JD Health's revenue for H1 2025 reached RMB 35.29 billion, representing a year-on-year growth of 24.5%, driven by strong demand for pharmaceutical and health products [3][14]. - The company's gross margin improved to 25.2%, with operating profit increasing by 105.5% to RMB 2.13 billion, indicating robust profitability growth [4][15]. - The deployment of AI technology is enhancing operational efficiency and long-term competitiveness, with over 500 AI agents launched in JD Internet Hospital [4][16]. Financial Performance Summary - Revenue projections for FY25 and FY26 are set at RMB 70.4 billion and RMB 81.2 billion, respectively, with expected growth rates of 21.0% and 15.4% [5][18]. - Adjusted net profit is forecasted to be RMB 5.6 billion for FY25, reflecting a 15.9% increase year-on-year [7][20]. - The company anticipates a continued strong performance in H2 2025, with pharmaceutical sales expected to grow by 25% [5][18]. Valuation and Forecast - A DCF valuation approach estimates the company's equity value at HKD 218.0 billion, leading to a target share price of HKD 68.14 [8][21]. - The report highlights the advantages JD Health holds in both supply and demand sides of the market, positioning it as a leader in the integrated online-offline healthcare sector [5][17].